GAMMA-SARCOGLYCANOPATHY

Clinical trials for GAMMA-SARCOGLYCANOPATHY explained in plain language.

Never miss a new study

Get alerted when new GAMMA-SARCOGLYCANOPATHY trials appear

Sign up with your email to follow new studies for GAMMA-SARCOGLYCANOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Study withdrawn before launch: planned research to map rare muscle disease

Knowledge-focused Terminated

This study aimed to track how a rare genetic muscle disease (LGMDR5) changes over two years in patients aged 6 to 35. It planned to measure walking, arm function, breathing, and muscle health to better understand the disease. The goal was to gather information to help design futu…

Matched conditions: GAMMA-SARCOGLYCANOPATHY

Sponsor: Atamyo Therapeutics • Aim: Knowledge-focused

Last updated Mar 18, 2026 14:41 UTC

GAMMA-SARCOGLYCANOPATHY

Get alerted when new GAMMA-SARCOGLYCANOPATHY trials appear

Study withdrawn before launch: planned research to map rare muscle disease